Atara Biotherapeutics, Inc. (ATRA)
NASDAQ · Healthcare
Atara Biotherapeutics, Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 120.8M | 128.9M | 8.6M | 63.6M |
| Gross Profit | — | — | — | — |
| Profitability | ||||
| Operating Income | 35.9M | -83.4M | -276.0M | -280.5M |
| EBITDA | 38.0M | -78.4M | -271.2M | -274.9M |
| Net Income | 32.7M | -85.4M | -276.1M | -228.3M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 13M | 7M | 4M | 102M |
Atara Biotherapeutics, Inc. Income Statement — FAQ
Atara Biotherapeutics, Inc. (ATRA) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATRA's income statement history?
The chart and table above show Atara Biotherapeutics, Inc.'s income statement by year and by quarter, including the growth rate.